Crescendo Biologics' Series A - II Round

Crescendo Biologics raised a round of funding on April 04, 2014. Investors include EMBL Ventures.

Crescendo Biologics, based in Cambridge, UK, is focused on the discovery and development of best-in-class human VH antibody fragment therapeutics using its novel transgenic platform. Crescendo is enab…

Articles about Crescendo Biologics' Series A - II Round: